Skip to content

The Effect of Hypnosis on Periodontal Treatment

The Effect of Hypnosis on Healing in Patients Undergoing Phase I Periodontal Therapy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06808373
Enrollment
50
Registered
2025-02-05
Start date
2024-11-18
Completion date
2026-11-18
Last updated
2025-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Anxiety, Peridontal Disease

Keywords

periodontitis, hypnosis, dental anxiety

Brief summary

Treatment of periodontal diseases relies on the mechanical removal of microbial dental plaque, calculus, and necrotic cementum from root surfaces in both supra- and subgingival areas to control inflammation in periodontal tissues. As in all dental treatments, dental phobia and dental anxiety are common challenges in initial periodontal therapy. Hypnosis is among the traditional non-pharmacological behavior management techniques used to manage stress and improve pain tolerance. It is known that hypnosis is effective in anxiety control in dentistry. The use of salivary levels of inflammatory mediators released during the disease is a valid method for assessing the progression of periodontal disease and healing after treatment. In this study, the effect of hypnosis on healing in patients undergoing Phase I periodontal therapy will be evaluated by comparing the mean differences in cytokine levels between case and control groups

Interventions

BEHAVIORALhypnosis

Hypnosis will be applied to periodontitis patients

Sponsors

Afyonkarahisar Health Sciences University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Being between the ages of 20-65 Not having any systemic disease Having chronic periodontal disease Having the ability to understand the study and answer questions

Exclusion criteria

Having any systemic disease Being under 20 or over 65 Not having any periodontal disease

Design outcomes

Primary

MeasureTime frame
measurement of cytokine levelsPre-treatment (day 0), post-treatment (day 0) and 8 weeks post-treatment

Countries

Turkey (Türkiye)

Contacts

Primary ContactKübra Karaçam Karaçam, Assistant Professor
kubrakaracam@hotmail.com+90 505 939 62 58

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026